Bispecific Antibodies in R/R FL and R/R DLBCL
Aligning on Clinical Best Practices

CME/CNE/CPE

Chicago Hilton
Sunday, June 1, 2025 | 6:45 PM - 8:15 PM CT

Join us for an enlightening 90-minute live symposium designed exclusively for hematologists and oncologists treating relapsed/refractory (R/R) follicular lymphoma (FL) and R/R diffuse large B-cell lymphoma (DLBCL). As the landscape evolves, staying abreast of innovative therapies is crucial for optimizing patient outcomes.

This symposium offers a unique opportunity to engage with leading experts in the field, gain insights from clinical trial data, and explore practical applications of bispecific antibody therapy in your practice.
 

	Gilles Salles, MD, PhD Chair Professor of Medicine, Chief of the Lymphoma Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, New York
	Joshua Brody, MD Panelist Director, Lymphoma Immunotherapy Program, Icahn School of Medicine at Mount Sinai, Hess Center for Science and Medicine, New York, New York
	Tycel Phillips, MD Panelist Associate Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California